The Cooper Companies, Inc. (NASDAQ:COO) Receives $110.25 Consensus Target Price from Analysts

Shares of The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) have received an average rating of "Moderate Buy" from the ten brokerages that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $110.25.

COO has been the topic of several recent analyst reports. Stifel Nicolaus reduced their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Citigroup cut their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Piper Sandler reissued an "overweight" rating and set a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Finally, BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th.

Cooper Companies Stock Performance

Shares of COO stock traded up $0.98 during trading hours on Friday, hitting $81.82. 160,716 shares of the company were exchanged, compared to its average volume of 1,416,919. The firm has a fifty day simple moving average of $82.37 and a 200 day simple moving average of $93.11. Cooper Companies has a 52-week low of $69.81 and a 52-week high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $16.36 billion, a price-to-earnings ratio of 41.96, a P/E/G ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Research analysts predict that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Institutional Trading of Cooper Companies

A number of hedge funds have recently bought and sold shares of the business. Byrne Asset Management LLC purchased a new stake in Cooper Companies in the fourth quarter valued at approximately $33,000. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies during the fourth quarter worth about $34,000. City Holding Co. acquired a new stake in shares of Cooper Companies during the first quarter worth $34,000. New Age Alpha Advisors LLC purchased a new stake in shares of Cooper Companies in the fourth quarter valued at about $38,000. Finally, Covestor Ltd boosted its stake in shares of Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after buying an additional 120 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.